Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emsam in Borderline Personality Disorder
NCT01912391Phase 3Completed
- Sponsor
- Mood and Anxiety Research
- Start
- Oct 2012
- Primary completion
- Mar 2015
- Countries
- 1
01
Overview
A Phase 3 trial of selegiline transdermal patch in borderline personality disorder (BPD), sponsored by Mood and Anxiety Research. Started Oct 2012; status: completed.
02
Drugs
selegiline transdermal patch
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT01912391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01912391.